Member Info for Dr_Horrible

Health From The Gut doesn’t seem to include FF.

https://www.dsm.com/content/dam/dsm/human-nutrition/pdfs/aw-100897-dsm-hfg-brochure.pdf

I cannot access BH.

It seems a fairly big company.

Been trying to find more info on Nao medical with their FF, Grape, Watermelon and Omega 4 (according to URL), but can’t find anything on it. I can’t even find that page from their site, I got the link on Google.

It would seem Nao Medical have taken on FF+O3. Hopefully that leads to some good sales and more deals are to come.

Fruitflow + Watermelon + Grape + Omega 3

Nao Medical is a leading digital health platform, delivering comprehensive healthcare solutions for over a decade. With 13+ physical locations, our commitment spans physical health, mental health, wellness, diet, nutrition, and more. We bridge healthcare gaps by providing informative, accessible, and high-quality care online and in person.

What is Fruitflow Omega 3?

Fruitflow Omega 3 is a unique blend of natural ingredients that work together to support your body's health. It contains a combination of fruit extracts, including tomato, watermelon, and grape, which are rich in antioxidants and other beneficial compounds.

https://naomedical.com/info/benefits-of-fruitflow-omega-4.html

Watermelon and grape?

we all know this share ain't going anywhere until we get big news, or turn a profit and get meaningful forecasts. yet, it still gets you down when it drags its **** along the floor like a dog with worms.

Hopefully!!! Read the Half Year Report RNS and the Capital Structure and Funding RNS. Waiting on positive news on multiple fronts.

It’s back again now.

What did it say?

If total Fruitflow sales equated to say £3m or whatever figure you guess, then initial BH orders will add ‘multiple’ of that. The total prospective sales pipeline stands at significant multiples of it. It’s gonna do wonders for the market cap. But for now, in the words of Bon Scott, it ain’t no fun waiting around to be a millionaire.

I would rather an offer after BH launch, BH customers launch, DSM launches products, DSM customers launch products, multiple products are available in India and Bangladesh and it is available on the shelf when I go to Tesco.

I would expect the price to come down lots when China orders come in. The huge volumes will drive down production costs. This will lead to more profit on existing customer sales.

150 vs 850 wasn’t it?

Yep, we wi have been trading for 5 months, but only get 2 months of data in Sept, which may not be clear. 6 months from April to September, reported in December, will be where we get clarity, unless we get a trading update before that.

So 6 months into the new agreement, we should have sales revenue of perhaps £1.5m and profits materially ahead of what we would have received under the old agreement. We will get an idea in September, but December should give us a clear picture of the current status. We can then start to understand what significant multiples of total FF sales may actually mean.

If I recall correctly, the profit was after production costs and DSM sales team and marketing costs. DSM we’re allowed to charge an amount for themselves. So we will no longer pay that, then the profit share will be more to us.

This section of the Full Year RNS tells me that the DSM agreement massively favoured DSM, but they couldn’t do anything about that. Hopefully the new transition agreement is far more fair to PXS.

For the past twelve years, due to the terms of the Alliance Agreement, Provexis has been largely dependent on DSM in respect of the development, production, marketing and commercialisation of Fruitflow, and Provexis' long-term success has been largely dependent on the ability of DSM to sell Fruitflow.

It has been noted in prior years that Provexis' negotiating position with DSM could have been affected by its size and limited cash resources relative to DSM which has substantial cash resources and established levels of commercial success. An inability to enter into any discussions with DSM on equal terms could have led to reduced revenue from the Alliance Agreement which may have had a significant adverse effect on Provexis' business, financial condition and results.